During that window, the manufacturer must negotiate formulary placement to generate the revenue needed to justify the original R&D investment, which the Tufts Center for the Study of Drug Development estimated at approximately $2.6 billion per approved drug (2023 update, including cost of capital)
it's also about adhering to the product's intended purpose
Despite Kaken Pharmaceutical sublicensing North American rights to Wyeth, the compound never completed the FDA approval process
But the trial-level evidence for safety and efficacy is limited
I listened to all of it, relieved that the tres leches cake that was offered to her when her preferred slice was unavailable turned out to be a thrilling substitute
This research specifically focused on people with type 2 diabetes, so more research is needed in other groups, and the results should not be generalized